Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000904454-24-000667·ASSEMBLY BIOSCIENCES, INC.
Schedule 13D ownership disclosure
ASSEMBLY BIOSCIENCES INC
Common Stock, par value $0.001 · CUSIP: 045396108
Event date: 2024-12-19
- Filing-level shares
- 2,209,471.00
- Percent of class
- 29.9%
- Gilead Sciences, Inc.Reported CIK 0000882095
Shares: 2,209,471.00 · Class: 29.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-24-000667
- Form type
- SCHEDULE 13D/A
- Filer
- ASSEMBLY BIOSCIENCES, INC.
- CIK
- CIK 1426800
- Filed
- Dec 23, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13D beneficial ownership